Is MIMEDX GROUP, INC. (MDXG) Halal?

NASDAQ Healthcare United States $566M
✓ HALAL
Confidence: 95/100
MIMEDX GROUP, INC. (MDXG) is Halal under 3 of 5 Shariah screening standards, including AAOIFI Standard 21. With a debt ratio of just 2.7% against the AAOIFI threshold of 30%, MIMEDX GROUP, INC. comfortably passes the key financial ratio tests. The company operates in the Healthcare sector (Biotechnology), which is not a prohibited industry under Islamic finance principles.

Shariah Screening — 5 Standards

Based on financial data from December 2025

Standard Debt Ratio Cash Ratio Receivables Income Status
AAOIFI 2.7%
/ 30%
24.8%
/ 30%
11.3%
/ 30%
0.13%
/ 5%
✓ HALAL
DJIM 2.7%
/ 33%
24.8%
/ 33%
11.3%
/ 33%
0.13%
/ 5%
✓ HALAL
MSCI 5.2%
/ 33%
48.5%
/ 33%
22.1%
/ 33%
0.13%
/ 5%
✗ NOT HALAL
S&P 2.7%
/ 33%
24.8%
/ 33%
11.3%
/ 33%
0.13%
/ 5%
✓ HALAL
FTSE 5.2%
/ 33%
48.5%
/ 33%
22.1%
/ 50%
0.13%
/ 5%
✗ NOT HALAL

Financial Highlights

P/E Ratio
11.9
Forward: 14.8
EPS
$0.32
P/B Ratio
2.2
EV/EBITDA
5.4
EV: $422M
Revenue
$419M
Growth: 27.1%
Beta
1.6
High volatility
Current Ratio
4.3

Profitability

Gross Margin 82.6%
Operating Margin 17.8%
Net Margin 11.6%
Return on Equity (ROE) 21.6%
Return on Assets (ROA) 13.2%

Cash Flow & Balance Sheet

Operating Cash Flow$74M
Free Cash Flow$73M
Total Debt$18M
Debt-to-Equity8.8
Current Ratio4.3
Total Assets$343M

Price & Trading

Last Close$3.94
50-Day MA$4.88
200-Day MA$6.35
Avg Volume1.0M
Beta1.6
52-Week Range
$3.81
$7.99

About MIMEDX GROUP, INC. (MDXG)

CEO
Mr. Joseph H. Capper
Employees
808
Sector
Healthcare
Industry
Biotechnology
Country
United States
Exchange
NASDAQ
Market Cap
$566M
Currency
USD

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company processes the human placental tissues membrane, and umbilical cord and the placental disc utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins, including cytokines, chemokines, and growth factors. Its patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. The company's wound care products include EPIFIX, EPICORD, EPIXPRESS, CHORIOFIX, EMERGE, CELERA, REGENKIT WOUND GEL, and EPIEFFECT sheets for use as protective barriers that enables a healthcare provider to select an appropriate size graft based on the size of the wound to reduce product waste. Its surgical and other product offerings consist of AMNIOFIX, AMNIOBURN, AMNIOCORD, AXIOFILL, HELIOGEN, and AMNIOEFFECT for applications in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery, and various orthopedic repairs and reconstructions. The company's products are used in the areas of wound care, burn, and surgical fields in healthcare. It sells its products through direct sales force and independent sales agents, as well as to individual customers and independent distributors in the United States. The company has a strategic alliance with Vaporox, Inc. for the promotion of their wound care offerings. The company was founded in 2006 and is headquartered in Marietta, Georgia.

Purification Calculator

As a halal stock with 0.13% impermissible income, you need to purify your dividends.

Enter your dividends to calculate purification amount

Related Halal Stocks in Healthcare

Frequently Asked Questions

Is MIMEDX GROUP, INC. (MDXG) halal to invest in?

Based on our screening using AAOIFI Standard 21 (the strictest methodology), MIMEDX GROUP, INC. is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.

What is MIMEDX GROUP, INC.'s debt ratio?

MIMEDX GROUP, INC.'s debt ratio is 2.7% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 5.2%.

Does MIMEDX GROUP, INC. require dividend purification?

Yes, MIMEDX GROUP, INC. has an impermissible income ratio of 0.13%, which means 0.13% of any dividends received should be donated to charity as purification. This is because a small portion of the company's revenue comes from non-Shariah-compliant sources.

What are MIMEDX GROUP, INC.'s key financial metrics?

MIMEDX GROUP, INC. has a market capitalization of $566M, trailing P/E ratio of 11.9, and revenue of $419M. The company maintains a gross margin of 82.6% and a net margin of 11.6%. Return on equity stands at 21.6%.

How often is the screening data updated?

Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.

Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.